Second-year MBBS student arrested for Black marketing of Remdesivir

Published On 2021-04-24 06:00 GMT   |   Update On 2021-04-26 05:40 GMT
Advertisement

Udaipur: Following an operation by the Special Task Force of Udaipur, a second-year MBBS student along with a private hospital doctor has been held for allegedly being involved in black-marketing of Remdesivir vials, the life-saving drug for the fight against Covid-19.

The medical student, a resident of Dungarpur and the Doctor, a resident of Savina were caught red-handed from Eklingpura Chouraha for selling Remdesivir vials for Rs 35,000 each.

Advertisement

According to Police, the UG medico and the doctor together had sold 46 vials in the past three days at abnormally high prices when the vials originally cost Rs 899 each.

Also Read: After Sir Ganga Ram Hospital, 20 AIIMS doctors, 6 medical students test positive for Covid-19

As per the latest media report by the Times of India, the accused reportedly told police about getting the vials from an employee of MB hospital against a cost of Rs 23,000 each.

The daily further mentions that after getting several tips regarding the black-marketing of Remdesivir vials, undercover police called the accused posing as a customer and expressed his urgent need for the Remdesivir vials. The doctor fixed the price at Rs 35,000 for each vial and refused any consideration claiming that he himself got them for Rs 23,000.

Also Read: Monitor supply of drugs under COVID Treatment Protocol including Remdesivir, Toclizomab: MHA to States, UTs

Following this, the police personnel agreed and the accused doctor allegedly asked him to come to Eklingpura Chouraha for sealing the deal. While police caught the doctor red-handedly during the deal, the MBBS student was found to be standing at a distance.

The police are currently interrogating the accused as they could possibly be part of a larger network of black marketers across the division.

Also Read: Only 2 years for FMGs to clear Screening tests in India after MBBS abroad: NMC releases new draft regulation

Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News